![west virginia glp-1 digestive blockage attorney Veterans and Ozempic Zepbound Lawsuit [2026] | Gastrointestinal](https://www.vet.law/wp-content/uploads/2024/08/Veterans-and-Ozempic-VetLaw-768x512.webp)
west virginia glp-1 digestive blockage attorney Veterans and Ozempic Zepbound Lawsuit [2026] | Gastrointestinal
Description
However, gastrointestinal side effects related to GLP-1 RA need appropriate clinical management to mitigate risks and maximize the benefits of therapy in people with IBD
![west virginia glp-1 digestive blockage attorney Veterans and Ozempic Zepbound Lawsuit [2026] | Gastrointestinal](https://www.torhoermanlaw.com/wp-content/uploads/2026/02/Zepbound-Lawsuit-Evidence-Commonly-Reviewed-in-GLP-1-Lawsuits-torhoerman-law.jpg)
Maintain energy balance
![west virginia glp-1 digestive blockage attorney Veterans and Ozempic Zepbound Lawsuit [2026] | Gastrointestinal](https://wvattorneys.com/wp-content/uploads/2024/10/Persons-Hands-Preparing-Semaglutide-Ozempic-Injection-1024x576.jpg)
Tirzepatide (Mounjaro) is a dual-action medication for type 2 diabetes and obesity, offering blood sugar control and weight loss, with potential side effects.
![west virginia glp-1 digestive blockage attorney Veterans and Ozempic Zepbound Lawsuit [2026] | Gastrointestinal](https://mixxhealthandwellness.com/wp-content/uploads/2025/03/glp-1-1024-768x768.png)
PlexusDx helps patients navigate semaglutide therapy after cholecystectomy with personalized dosing and genetic insights
![west virginia glp-1 digestive blockage attorney Veterans and Ozempic Zepbound Lawsuit [2026] | Gastrointestinal](https://www.richmondvona.com/wp-content/uploads/2026/02/woman-holding-an-apple-with-a-measure-tape-around-2026-01-09-14-50-38-utc-scaled.jpg.webp)
GLP-1 drugs work
![west virginia glp-1 digestive blockage attorney Veterans and Ozempic Zepbound Lawsuit [2026] | Gastrointestinal](https://static.time.com/v3/assets/bltea6093859af6183b/bltb0b47a42fda92bf9/698a90ff9862f5f63b89b88f/glp-1-drugs.jpg?branch=production&width=2400&quality=75&auto=webp)
A new KFF analysis estimates that 3.8 million Medicare Part D enrollees could qualify for the Medicare GLP-1 Bridge program, which began July 1 and provides temporary coverage of GLP-1s for weight reduction for eligible beneficiaries through December 2027.
![west virginia glp-1 digestive blockage attorney Veterans and Ozempic Zepbound Lawsuit [2026] | Gastrointestinal](https://www.seegerweiss.com/wp-content/uploads/2023/10/AdobeStock_501320442-1-scaled.jpeg)
